Bayview Acquisition Corp

The vote permanently removes the June 19, 2026 termination date, preventing automatic winding up and preserving capital for the ongoing acquisition process. The modest $1,493,596.68 withdrawal against the full trust balance demonstrates concentrated redemption activity rather than broad sell-offs, protecting per-share liquidity for remaining public holders. The $50,000 monthly fee establishes a precise, predictable extension cost schedule through December 19, 2026. Chief Executive Officer Xin Wang attributed the voting outcome to shareholder 'continued confidence' in the company’s trajectory toward a merger with Oabay Inc., which he described as a provider of trade credit digital transformation solutions—including supply chain finance and trade credit management cloud services—operating in the Chinese market for more than ten years.

This filing materially decouples the contractual merger timeline from Nasdaq compliance requirements; while the agreement now permits closing as late as December 19, 2026, the exchange’s conditional panel decision forces a hard merger deadline of June 19, 2026 to retain listings. Per-share trust value growth is currently sustained almost exclusively by target-sponsored loans ($1,925,000 in advances), effectively deferring redemption pricing pressures without generating intrinsic yield. Management’s issuance of a going concern notice, citing a $4,035,754 working capital deficit and mere $50,187 in operating cash, confirms the SPAC possesses no independent liquidity to finance further extensions or administrative operations, making the entire continuation strategy dependent on continuous Oabay funding and successful Nasdaq listing maintenance.

The extension resets the hard redemption and trust distribution horizon to December 19, 2026, giving public shareholders until that date to opt out before the trust remains deployed or the merger finalizes. The multi-amendment timeline reflects prolonged preparation, yet the deal mechanics remain intact without introducing new financial targets or shareholder approval triggers. Per the signature pages attached to the amendment, execution was authorized by SPAC CEO Xin Wang; Sponsor principals Taylor Zhang (Bayview Holding LP) and Pengfei Zheng (Peace Investment Holdings Limited); and Target/PubCo directors Yuk Man Lau and Xiaoling Li. No claims regarding customers, market size, technology, partnerships, or litigation appear in the document.

By resetting the Outside Closing Date to December 19, 2026, the sponsor and target company delay the window for shareholder redemptions, voting, and trust account distributions. According to the filing, neither party will face termination rights until after this new date, provided neither side’s breach primarily caused the delay. The document references earnout milestones tied to consolidated revenue metrics, but attributes no specific financial targets, customer lists, market size assessments, litigation updates, or personnel changes to the submission. The extension signals that management requires additional time to satisfy closing conditions, but without disclosed milestones or revenue data in this filing, investors lack visibility into the operational or regulatory hurdles driving the prolongation of the merger timeline.

For investors tracking redemption windows, trust preservation, and sponsor compliance, a Form 12b-25 signals administrative lag that compresses the disclosure timeline before shareholder votes or conversion triggers. Delayed 10-Q filings postpone public access to unaudited financials detailing trust interest accruals, working capital sufficiency, and SPAC liability movements—data required to evaluate early redemptions versus continuation.

The extension pushes the redemption and deal completion calendar forward by exactly one month. The registrant explicitly characterizes this as the sixth and final extension permitted under its Second Amended and Restated Articles of Association. Because no further extensions are contractually allowed, June 19, 2026 functions as a hard deadline for closing the transaction or triggering the fund's termination and liquidation redemptions. The $50,000 deposit simultaneously reduces the total trust balance, lowering the per-share amount available to redeeming or converting investors.

The extension supports efforts to finalize a merger agreement executed on June 7, 2024, with Oabay Holding Company, PubCo, Merger Sub 1, Merger Sub 3, and Oabay Inc., which the board unanimously approved pending shareholder clearance. However, the Nasdaq Listing Qualifications Department issued multiple deficiency notices regarding minimum market value and public holder thresholds, ultimately transferring the company to the Nasdaq Capital Market on April 24, 2026 under a panel decision that mandates closing the Oabay combination by June 19, 2026 and proving compliance with initial listing standards. The filing discloses that directors and officers maintain significant ties to the People’s Republic of China, Hong Kong, Taiwan, and Macau, creating CFIUS and foreign ownership hurdles that could restrict the target universe. As a shell company that raised $60,000,000 in gross proceeds from its December 19, 2023 IPO plus $2,325,000 from private placement units, but has generated zero operations or revenue, the board argues additional time is necessary given commitments already spent identifying a target. The company warns that failing to secure the extension votes, or failing to close the transaction by the extended deadline, will trigger automatic winding up, trust liquidation (minus up to $100,000 of interest for dissolution costs), and total forfeiture of the founders’ equity, whose underlying private placement and founder shares carry no liquidity or claim to the trust.

This proxy initiates a critical redemption window with a hard deadline of 5:00 p.m. Eastern Time on May 26, 2026. If shareholders redeem, the remaining cash shrinks, impacting the minimum net tangible assets condition of $5,000,001 and potentially jeopardizing the Oabay deal. The extension relies on Sponsors covering $50,000 monthly fees; failure to pay terminates the extension. With Initial Shareholders holding approximately 63.3% of outstanding Ordinary Shares, they hold decisive voting power, though the Extension Amendment still requires a two-thirds majority of votes cast, and the Trust Agreement Amendment requires sixty-five percent of all outstanding shares. The Nasdaq conditional exception directly links exchange compliance to the June 19, 2026, closing deadline, meaning failure to merge triggers both regulatory delisting and automatic liquidation protocols.

The Nasdaq mandate creates a hard June 19, 2026 milestone to consummate the Oabay merger and restore initial listing standards, directly compressing the window for redemption decisions and potentially triggering liquidation mechanics if the deal fails. Per the attached press release, Oabay provides trade credit digital transformation solutions consisting of supply chain finance cloud services and trade credit management cloud services, targeting small-to-medium-sized enterprises and leveraging experience in accounts receivable factoring and enterprise credit digitalization. The press release attributes to Oabay more than ten years of operating history and positions it as a pioneer in the Chinese trade credit technology solutions industry. Chief Executive Officer Xin Wang stated the company remains focused on completing the business combination and satisfying listing requirements, while explicitly disclaiming any assurance that the Panel's conditions will be met within the required timeframes. The filing notes the Panel reserves the right to reconsider the exception and requires prompt notification of significant events affecting compliance.

The revised May 19, 2026 deadline directly resets the upcoming redemption window and liquidation trigger, granting public shareholders approximately thirty-one days to decide whether to withdraw their capital before the trust is potentially distributed. By utilizing the fifth extension credit, the sponsor has consumed five of the six authorized extensions, severely limiting future runway unless the charter is amended. Beyond these mechanical adjustments, the filing contains no substantive disclosures regarding target candidates, proposed transaction valuations, customer concentrations, revenue streams, market sizing, technological capabilities, commercial partnerships, pending litigation, or operational executive roles beyond standard corporate contact information.

Listing non-compliance and a pending appellate hearing introduce secondary market liquidity risk and potential delisting procedures that may constrain shareholder liquidity ahead of the December 19, 2026 redemption window. As attributed to Nasdaq Staff communications and the Company’s 8-K disclosure signed by Chief Executive Officer Xin Wang on March 23, 2026, the 1,100,000 publicly held share threshold and market value deficit indicate structural holder distribution challenges without assurance of corrective action. These exchange-level requirements do not contractually force a trust liquidation or alter the $12.21 trust value per share or the redemption timeline, but they increase regulatory overhead, may depress trading volumes, and could widen bid-ask spreads prior to the deadline. Beyond listing rules, the filing contains no substantive claims regarding customer concentration, revenue, market size, commercial strategy, technology, partnerships, litigation, or executive personnel changes, as those topics fall outside the scope of this compliance-only submission.

Investors tracking the redemption calendar should note the compressed June 19, 2026 completion window creates tighter execution pressure, while the existence of an executed definitive agreement marks advanced deal progression ahead of the forthcoming combined company proxy/prospectus. Sponsor and insider voting control guarantees routine governance proposals pass without public shareholder input, but the active Nasdaq delisting proceedings and appeal hearing introduce near-term liquidity and trading viability risks that could complicate target outreach and future redemption dynamics. When the next proxy/prospectus is filed, investors will gain access to the precise redemption price, trust account composition, lock-up terms, and deal-specific financial projections.

This extension directly alters the redemption and liquidation mechanics by preserving the trust balance for another thirty days and deferring the redemption trigger. Because this represents the fourth of six allowable extensions, the filing indicates severely constrained runway for completing a merger before mandatory dissolution provisions activate. Beyond confirming the deposit and revised deadline, the document contains no substantive claims regarding acquisition targets, customer bases, revenue metrics, market size, technology platforms, strategic partnerships, litigation matters, or personnel changes. Chief Executive Officer and Director Xin Wang's signature is limited to certifying the extension deposit and updated schedule. The filing stands as the primary mechanical update for the week, overriding prior expectations by locking in a hard operational cutoff at April 19, 2026.

While this proxy handles standard governance renewals, it materially updates deal progress by acknowledging a binding agreement is already in place, signaling that a dedicated de-SPAC solicitation package is imminent and shifting the redemption window awareness forward. The explicit reliance on Sponsor-held capital (approximately 50.0% voting control) guarantees procedural approvals, but the documented Nasdaq delisting risks—coupled with acknowledged CFIUS scrutiny over foreign ownership ties to the People’s Republic of China and potential Investment Company Act classification—could constrain target pools, depress secondary liquidity, and complicate financing before the June 19, 2026 termination date. Investors awaiting specific valuation metrics, redemption mechanics, and target identification must wait for the subsequent business combination proxy/prospectus referenced in the filing.

The aggressive redemption wave has shrunk the public float and drained operating liquidity down to $44,129, forcing reliance on unsecured promissory notes totaling $1,775,000 to fund extensions and underscoring the management-reported going concern risk. The Nasdaq delisting notification introduces immediate listing jeopardy that could disrupt secondary market trading and complicate the transaction financing required for the deal, though the scheduled March 31, 2026 appeal hearing provides a procedural buffer. By formally amending the Merger Agreement to June 15, 2026, the company secures additional operational runway to satisfy closing conditions, align audit expectations under the Holding Foreign Companies Accountable Act, and potentially meet revised revenue targets, but investors face heightened uncertainty that insufficient trust liquidity, persistent regulatory hurdles, or failure to navigate the Nasdaq appeals process could ultimately force a liquidation where private placement units and rights expire worthless.

The impending delisting threatens trading liquidity and secondary market visibility ahead of the stated merger deadline. The filing does not modify the trust mechanics or redemption calendar directly, but it highlights persistent administrative and corporate governance lapses managed by leadership, evidenced by the prior compliance notice dating back to August 26, 2025. Chief Executive Officer Xin Wang signed the February 24, 2026 amendment, indicating management intends to appeal to a Nasdaq Hearings Panel by February 26, 2026, though the document cautions there can be no assurance of a successful outcome. No new customer claims, revenue projections, market size estimates, technology disclosures, partnership announcements, or active litigation details beyond the exchange hearing process are contained herein.

For investors monitoring SPAC redemption windows, trust per-share value, extension voting, and business combination execution against the December 19, 2026 deadline, this filing introduces immediate listing-status risk that directly threatens public market liquidity and shareholder pricing transparency. The documented inability to restore either the $50.0 million aggregate market value threshold or the $15.0 million publicly held shares threshold indicates sustained valuation compression, which frequently pressures sponsors to call for extension votes, restructure deal timelines, or face accelerated redemption campaigns. The explicit administrative admission regarding the missed annual meeting further highlights governance and procedural delays commonly associated with stretched SPAC lifecycles. While the document contains no forward projections, customer disclosures, revenue metrics, technology roadmaps, or partner agreements, the combination of dual market-value deficiencies and governance lateness signals elevated execution friction ahead of the merger deadline. The February 26 appellate window serves as a definitive near-term catalyst: approval preserves exchange eligibility for transaction financing, whereas denial triggers delisting, OTC trading conditions, and potential restructuring pathways that could alter trust distribution mechanics or redemption calculus for public shareholders.

This administrative notice does not alter the SPAC’s stated redemption deadline or trust per share value, but the missed annual meeting reflects a procedural gap that could complicate future proxy logistics required for a business combination vote. Successfully navigating the March 30, 2026 filing window and securing the June 29, 2026 extension will preserve Nasdaq listing status, ensuring public market liquidity and institutional compliance remain intact while management advances deal execution. The filing contains no disclosures regarding customer contracts, revenue streams, market positioning, technology, strategic partnerships, litigation, or leadership changes beyond the signing of the report.

The extension shifts the relevant redemption and liquidation horizon from mid-February to mid-March 2026, giving management additional time to locate a target. Paid extensions inject cash into the trust but do not advance deal progress, negotiate a business combination, or signal sponsor conviction beyond willingness to fund further delays. The document contains no claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or other operational developments. Investors should weigh the cost of sequential extensions against the remaining statutory runway when evaluating redemption timing around the new March 19 deadline.

The extension to June 15, 2026 defers any default or termination triggers tied to the original closing timeline, keeping shareholder capital in the trust longer than previously structured. The Nasdaq compliance mandate introduces near-term liquidity and administrative risk: management’s representation notes the company will “monitor its MVPHS and consider its available options to regain compliance,” while explicitly disclaiming any guarantee of success before the July 15, 2026 cutoff. Missing the threshold triggers a formal delisting notice, followed by an appeal opportunity, which could fundamentally alter trading mechanics and redemption pathways. Additionally, the renewed focus on “new consolidated revenue metrics” for earnouts indicates that commercial performance targets remain legally binding post-closing, even after the sequencing adjustments finalized in May 2025. All disclosures, dates, thresholds, and procedural steps were stated by the registrant and its designated officers, including Chief Executive Officer Xin Wang and Sponsor representatives.

The June 15, 2026 contractual milestone directly reshapes the transaction timeline relative to the December 19, 2026 liquidation deadline, establishing a definitive checkpoint that influences when redemption windows effectively close versus when mandatory dissolution triggers activate. The Nasdaq deficiency introduces immediate exchange listing risk; if the $15.0 million threshold is not maintained for ten straight trading days within the 180-day window, the company faces delisting notification, which typically threatens merger conditions and accelerates shareholder exit calculations. The amendment preserves mutual termination rights through the new date while explicitly limiting liability to parties whose primary breach caused delays, clarifying sponsor and target conduct accountability.

Substance & Context: Beyond the extension mechanics, the filing contains no additional claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel changes. Standard corporate identifiers (principal executive offices at 420 Lexington Ave, Suite 2446, New York, NY 10170; Nasdaq trading symbols BAYAU, BAYA, BAYAR; and emerging growth company classification) appear on the cover page. Because Chief Executive Officer and Director Xin Wang executed the report on January 15, 2026, investors must weigh the delayed timeline against the company’s remaining extension capacity and the pre-existing $12.21 per share trust value when deciding whether to hold shares, exercise redemption rights, or prepare for a proxy vote as the February 19, 2026 date approaches.

The $50,000 deposit directly alters the per-share trust accrual trajectory heading into the new January 19, 2026, redemption window, meaning shareholders who elect to exit at month-end will receive a trust value adjusted upward by the extension fee rather than seeing it erode from standard monthly deductions. The $300,000 promissory note demonstrates sponsor conduct where financing for the extension pipeline is being supplied by the target entities themselves, deferring any cash outflow or shareholder dilution until merger closing. For investors tracking deal progress, the document narrows the target universe to Oabay Inc. and AsiaFactor(CN) Co., Ltd. and establishes a fixed, one-month runway under the amended Articles of Association, allowing redemption timers to be recalibrated against the January 19, 2026, cutoff.

The filing directly revises the redemption calendar by setting June 19, 2026 as the new deadline and establishes a transparent cost structure for delaying liquidation ($50,000 per extension funded by sponsors and deposited into the Trust Account). The redemption of 727,970 shares at approximately $11.62 per share removes approximately $8,459,011.4 from the trust balance, immediately reducing the capital pool available to consummate an initial business combination and adjusting the residual per-share value if winding-up procedures are triggered. The filing confirms there are no disclosures regarding target company operations, customer contracts, revenue figures, market positioning, technology assets, strategic partnerships, ongoing litigation, or executive compensation changes. All substantive parameters remain confined to corporate governance timelines, trust funding obligations, and post-vote redemption accounting as reported by the registrant and signed by management.

What changed: An amendment to a Current Report on Form 8-K that updates the projected redemption price per share and reports the results of a shareholder vote on extending the business combination deadline and amending the trust agreement. Bayview Acquisition Corp reports in this filing that it revises the projected redemption price previously disclosed in the Original Form 8-K dated June 3, 2026. The company states that at an extraordinary general meeting on May 28, 2026, shareholders approved extending the termination date from June 19, 2026 to December 19, 2026 via six one-month extensions. Bayview further reports approving amendments to its investment management trust agreement with Equiniti Trust Company, LLC to permit these extensions upon five days’ advance notice and deposits of $50,000 per extension into the Trust Account until December 19, 2026. The company discloses that ten holders redeemed 124,156 Ordinary Shares at approximately $12.11 per share, yielding an aggregate redemption amount of approximately $1,503,642.93. According to the registrant, voting attendance represented approximately 83.67% of outstanding shares as of May 4, 2026, with 2,291,094 votes cast for each proposal. Why it matters: As reported by the company, the updated redemption price directly affects the cash return available to remaining public shareholders near the new deadline. The registrant highlights that the sponsor agreement to fund extensions at $50,000 each demonstrates capital commitment to delay liquidation. The filing notes the reduction of 124,156 shares lowers the denominator for future trust distributions. By moving the definitive resolution timeline from June 19, 2026 to December 19, 2026, the company provides itself additional months to execute a business combination without facing mandatory dissolution.

What changed: SEC Form 8-K current report and accompanying Regulation FD press release detailing shareholder approval of a corporate extension and reporting of limited redemptions. Bayview Acquisition Corp extended its deadline to consummate a business combination from June 19, 2026 to December 19, 2026, structured as six consecutive one-month extensions. Shareholders voted in favor with 2,291,094 ordinary shares represented (approximately 83.67% of outstanding shares as of May 4, 2026). In direct connection with the approval, ten holders redeemed 124,156 ordinary shares at approximately $12.03 per share, generating an aggregate redemption amount of $1,493,596.68. The investment management trust agreement was amended to authorize these extensions contingent on five days’ advance notice to the trustee and a sponsor deposit of $50,000 into the Trust Account for each monthly extension. Why it matters: The vote permanently removes the June 19, 2026 termination date, preventing automatic winding up and preserving capital for the ongoing acquisition process. The modest $1,493,596.68 withdrawal against the full trust balance demonstrates concentrated redemption activity rather than broad sell-offs, protecting per-share liquidity for remaining public holders. The $50,000 monthly fee establishes a precise, predictable extension cost schedule through December 19, 2026. Chief Executive Officer Xin Wang attributed the voting outcome to shareholder 'continued confidence' in the company’s trajectory toward a merger with Oabay Inc., which he described as a provider of trade credit digital transformation solutions—including supply chain finance and trade credit management cloud services—operating in the Chinese market for more than ten years.

What changed: Quarterly report on Form 10-Q for the period ended March 31, 2026. Management disclosed that on May 19, 2026, the parties to the Merger Agreement executed a Fourth Amendment extending the Outside Closing Date to December 19, 2026. As of March 31, 2026, the trust account balance stood at $12,014,746, up from $11,710,990 at December 31, 2025. This accretion comprised $103,756 in interest earned on investments and $150,000 in extension deposits. Management stated these deposits were funded by Oabay through eleven promissory notes totaling $1,925,000. Consequently, the carrying value per share subject to possible redemption increased to $11.95 from $11.69. The company reported a net loss of $367,344 for the quarter. Post-balance sheet disclosures indicate the Nasdaq hearings panel granted continued listing on April 22, 2026, requiring a transfer to The Nasdaq Capital Market by April 24, 2026, and mandating closure of the business combination with Oabay by June 19, 2026. Additional disclosures confirm two extension deposits of $50,000 each were made in April and May 2026, financed via Oabay arrangements. Why it matters: This filing materially decouples the contractual merger timeline from Nasdaq compliance requirements; while the agreement now permits closing as late as December 19, 2026, the exchange’s conditional panel decision forces a hard merger deadline of June 19, 2026 to retain listings. Per-share trust value growth is currently sustained almost exclusively by target-sponsored loans ($1,925,000 in advances), effectively deferring redemption pricing pressures without generating intrinsic yield. Management’s issuance of a going concern notice, citing a $4,035,754 working capital deficit and mere $50,187 in operating cash, confirms the SPAC possesses no independent liquidity to finance further extensions or administrative operations, making the entire continuation strategy dependent on continuous Oabay funding and successful Nasdaq listing maintenance.

What changed: A Form 8-K reporting the execution of Amendment No. 4 to the Agreement and Plan of Merger between Bayview Acquisition Corp and Oabay Inc. The Outside Closing Date for the proposed business combination was formally extended from June 15, 2026, to December 19, 2026. The filing chronicles prior amendments: Amendment No. 1 (dated June 26, 2024) revised earnout milestones to reflect new consolidated revenue metrics; Amendment No. 2 (dated May 14, 2025) realigned the sequence of transactions; and Amendment No. 3 (dated January 21, 2026) initially pushed the deadline to June 15, 2026. Why it matters: By resetting the Outside Closing Date to December 19, 2026, the sponsor and target company delay the window for shareholder redemptions, voting, and trust account distributions. According to the filing, neither party will face termination rights until after this new date, provided neither side’s breach primarily caused the delay. The document references earnout milestones tied to consolidated revenue metrics, but attributes no specific financial targets, customer lists, market size assessments, litigation updates, or personnel changes to the submission. The extension signals that management requires additional time to satisfy closing conditions, but without disclosed milestones or revenue data in this filing, investors lack visibility into the operational or regulatory hurdles driving the prolongation of the merger timeline.

What changed: Form 8-K filed pursuant to Securities Act Rule 425, functioning as a written communication that discloses Amendment No. 4 to the Agreement and Plan of Merger between Bayview Acquisition Corp and Oabay Inc. As reported by the registrant in Item 1.01 and detailed in Exhibit 2.1, Amendment No. 4, dated May 19, 2026, extends the Outside Closing Date from June 15, 2026 to December 19, 2026. The amendment restates Section 13.1(b) to allow either party to terminate the agreement if closing has not occurred by the new date, while preserving the standard carve-out that bars termination rights from any party whose breach primarily caused the failure to close. This builds on three prior contractual revisions disclosed in the same filing: Amendment No. 1 (June 26, 2024) modified earnout milestones to track new consolidated revenue metrics; Amendment No. 2 (May 14, 2025) realigned the transaction sequence; and Amendment No. 3 (January 21, 2026) previously shifted the deadline to June 15, 2026. Why it matters: The extension resets the hard redemption and trust distribution horizon to December 19, 2026, giving public shareholders until that date to opt out before the trust remains deployed or the merger finalizes. The multi-amendment timeline reflects prolonged preparation, yet the deal mechanics remain intact without introducing new financial targets or shareholder approval triggers. Per the signature pages attached to the amendment, execution was authorized by SPAC CEO Xin Wang; Sponsor principals Taylor Zhang (Bayview Holding LP) and Pengfei Zheng (Peace Investment Holdings Limited); and Target/PubCo directors Yuk Man Lau and Xiaoling Li. No claims regarding customers, market size, technology, partnerships, or litigation appear in the document.

What changed: Form 8-K current report itemizing a SPAC extension payment and corresponding trust account deposit. The filing states that Bayview Acquisition Corp deposited $50,000 into its trust account on May 15, 2026. Per the registrant, this action extends the deadline to consummate an initial business combination from May 19, 2026 to June 19, 2026. Chief Executive Officer and Director Xin Wang signed the document on behalf of the company. Why it matters: The extension pushes the redemption and deal completion calendar forward by exactly one month. The registrant explicitly characterizes this as the sixth and final extension permitted under its Second Amended and Restated Articles of Association. Because no further extensions are contractually allowed, June 19, 2026 functions as a hard deadline for closing the transaction or triggering the fund's termination and liquidation redemptions. The $50,000 deposit simultaneously reduces the total trust balance, lowering the per-share amount available to redeeming or converting investors.

What changed: This document is a Form 12b-25, Notification of Late Filing, submitted to the U.S. Securities and Exchange Commission by Bayview Acquisition Corp to formally excuse a delay in filing its Quarterly Report on Form 10-Q for the period ended March 31, 2026. Per Chief Executive Officer Xin Wang, the Registrant cannot file the quarterly report within the standard window without unreasonable effort or expense because the financial statements for the March 31, 2026 quarter are still being prepared. The Company expects to submit the filing within five calendar days of the due date. Why it matters: For investors tracking redemption windows, trust preservation, and sponsor compliance, a Form 12b-25 signals administrative lag that compresses the disclosure timeline before shareholder votes or conversion triggers. Delayed 10-Q filings postpone public access to unaudited financials detailing trust interest accruals, working capital sufficiency, and SPAC liability movements—data required to evaluate early redemptions versus continuation.

What changed: This document is a routine compliance exhibit attached to a Schedule 13G filing, consisting of two Limited Powers of Attorney. FIRST, it is identified in its own terms as an administrative authorization instrument executed by Mizuho Financial Group, Inc., Mizuho Bank, Ltd., Mizuho Americas LLC, and Mizuho Securities USA LLC to empower Takahiro Katsura to sign SEC Form 13G documents. THEN, regarding SPAC mechanics, it reports zero modification to Bayview Acquisition Corp’s redemption deadline, trust share value, extension rights, target deal progress, or sponsor conduct; it functions exclusively as a proxy execution mechanism for regulatory submissions. THEN, regarding other substance, the filing states that the undersigned entities classify Mizuho Bank, Ltd. (at 1-5-5, Otemachi, Chiyoda-ku, Tokyo 100-8176, Japan) as a non-U.S. institution equivalent to Bank, Mizuho Americas LLC (at 1271 Avenue of the Americas, NY, NY 10020, USA) as a parent holding company, and Mizuho Securities USA LLC (at 1271 Avenue of the Americas, NY, NY 10020, USA) as a registered Broker-Dealer. All disclosures and assertions are attributed to Mizuho Financial Group, Inc., Mizuho Bank, Ltd., Mizuho Americas LLC, and Mizuho Securities USA LLC via signatures from Shuji Matsuura and Adam Hopkins, dated 5-14-2026. Establishment of an internal agent authorization for Form 13G execution; introduces no adjustments to redemption windows, trust account balances, extension procedures, business combination milestones, or sponsor oversight. Why it matters: Verifies that Mizuho entities are satisfying their Section 13(d) and Section 13(g) reporting obligations for BAYA securities through proper delegation, providing reassurance on regulatory compliance while confirming no shareholder-facing triggers, valuation shifts, or transaction timeline alterations have occurred.

What changed: A definitive proxy statement (SEC Form DEF 14A) convened by Bayview Acquisition Corp to solicit shareholder votes at an extraordinary general meeting on May 28, 2026, regarding an extension amendment proposal, a trust agreement amendment proposal, and an adjournment proposal. The Board proposes extending the business combination deadline from June 19, 2026 to December 19, 2026 via a special resolution requiring two-thirds of votes cast, paired with a Trust Agreement Amendment permitting up to six consecutive one-month extensions. According to the filing, each extension requires sponsors to deposit $50,000 into the trust account five days in advance in exchange for a non-interest-bearing, unsecured promissory note payable upon a business combination or forfeited upon liquidation if outside funds do not exist. Public shareholders may elect to redeem shares regardless of their vote, provided written requests are submitted by 5:00 p.m. ET on May 26, 2026, subject to a Charter provision stating redemptions cannot cause net tangible assets to fall below $5,000,001 after deferred underwriting commissions, nor exceed 15% of outstanding public shares per shareholder group without prior consent. On the May 4, 2026 record date, the trust account held approximately $12,103,085.50, which the board calculates yields a pro rata redemption price of approximately $12.03 per share against a Nasdaq closing price of $12.00. Initial shareholders controlling 1,732,500 ordinary shares (approximately 63.3% of the outstanding class) state they intend to vote in favor and have waived any right to participate in liquidating distributions. The Board confirms both extension and trust amendments are mutual conditions for implementation. Why it matters: The extension supports efforts to finalize a merger agreement executed on June 7, 2024, with Oabay Holding Company, PubCo, Merger Sub 1, Merger Sub 3, and Oabay Inc., which the board unanimously approved pending shareholder clearance. However, the Nasdaq Listing Qualifications Department issued multiple deficiency notices regarding minimum market value and public holder thresholds, ultimately transferring the company to the Nasdaq Capital Market on April 24, 2026 under a panel decision that mandates closing the Oabay combination by June 19, 2026 and proving compliance with initial listing standards. The filing discloses that directors and officers maintain significant ties to the People’s Republic of China, Hong Kong, Taiwan, and Macau, creating CFIUS and foreign ownership hurdles that could restrict the target universe. As a shell company that raised $60,000,000 in gross proceeds from its December 19, 2023 IPO plus $2,325,000 from private placement units, but has generated zero operations or revenue, the board argues additional time is necessary given commitments already spent identifying a target. The company warns that failing to secure the extension votes, or failing to close the transaction by the extended deadline, will trigger automatic winding up, trust liquidation (minus up to $100,000 of interest for dissolution costs), and total forfeiture of the founders’ equity, whose underlying private placement and founder shares carry no liquidity or claim to the trust.

What changed: PRE 14A Preliminary Proxy Statement for an Extraordinary General Meeting. The Board proposes amending the Existing Charter and Trust Agreement to extend the business combination deadline from June 19, 2026, to December 19, 2026. Each monthly extension requires the Sponsors to deposit $50,000 into the Trust Account in exchange for non-interest bearing promissory notes. Concurrently, the filing grants Public Shareholders immediate redemption rights to withdraw funds before any extension takes effect. Additionally, the Nasdaq Hearings Panel has conditionally approved continued listing on the Nasdaq Capital Market, stipulating that Bayview must close its pending business combination with Oabay Inc. by June 19, 2026. Why it matters: This proxy initiates a critical redemption window with a hard deadline of 5:00 p.m. Eastern Time on May 26, 2026. If shareholders redeem, the remaining cash shrinks, impacting the minimum net tangible assets condition of $5,000,001 and potentially jeopardizing the Oabay deal. The extension relies on Sponsors covering $50,000 monthly fees; failure to pay terminates the extension. With Initial Shareholders holding approximately 63.3% of outstanding Ordinary Shares, they hold decisive voting power, though the Extension Amendment still requires a two-thirds majority of votes cast, and the Trust Agreement Amendment requires sixty-five percent of all outstanding shares. The Nasdaq conditional exception directly links exchange compliance to the June 19, 2026, closing deadline, meaning failure to merge triggers both regulatory delisting and automatic liquidation protocols.